Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1988 Aug;47(8):665–671. doi: 10.1136/ard.47.8.665

Serum alpha 1 antichymotrypsin concentration as a marker of disease activity in rheumatoid arthritis.

M D Chard 1, J Calvin 1, C P Price 1, T E Cawston 1, B L Hazleman 1
PMCID: PMC1006719  PMID: 3261967

Abstract

Serum alpha 1 antichymotrypsin (alpha 1ACT), C reactive protein (CRP), orosomucoid, and erythrocyte sedimentation rate (ESR) were measured sequentially in 20 patients with rheumatoid arthritis (RA) treated with gold or penicillamine. Pain score, morning stiffness, grip strength, and articular index were measured and a Mallya score calculated. Based on a total of 148 sets of observations, significant correlations were found between alpha 1ACT and other variables (p less than 0.001 except morning stiffness at p less than 0.05). The actual correlation coefficients indicated a closer association with the other laboratory tests, CRP (0.62), orosomucoid (0.69), and ESR (0.61), than with clinical measurements: pain score (0.38), articular index (0.41), grip strength (-0.3), morning stiffness (0.19), and Mallya score (0.5). Sequential data on individual patients showed differing patterns of change in the variables indicating the importance of measuring more than one acute phase protein (APP), especially when CRP is inappropriately low. Serum alpha 1ACT concentration does reflect disease activity in RA. Its potential advantages are discussed.

Full text

PDF
671

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calvin J., Neale G., Fotherby K. J., Price C. P. The relative merits of acute phase proteins in the recognition of inflammatory conditions. Ann Clin Biochem. 1988 Jan;25(Pt 1):60–66. doi: 10.1177/000456328802500108. [DOI] [PubMed] [Google Scholar]
  2. Chambers R. E., MacFarlane D. G., Whicher J. T., Dieppe P. A. Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity. Ann Rheum Dis. 1983 Dec;42(6):665–667. doi: 10.1136/ard.42.6.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Docci D., Bilancioni R., Pistocchi E., Mosconi G., Turci F., Salvi G., Baldrati L., Orsi C. Serum alpha-1-acid glycoprotein in chronic renal failure. Nephron. 1985;39(3):160–163. doi: 10.1159/000183364. [DOI] [PubMed] [Google Scholar]
  4. Fischer C. L., Gill C., Forrester M. G., Nakamura R. Quantitation of "acute-phase proteins" postoperatively. Value in detection and monitoring of complications. Am J Clin Pathol. 1976 Nov;66(5):840–846. doi: 10.1093/ajcp/66.5.840. [DOI] [PubMed] [Google Scholar]
  5. Kjellstrand C. M. Dedication to Belding H. Scribner. Nephron. 1983;33(2):77–78. doi: 10.1159/000182916. [DOI] [PubMed] [Google Scholar]
  6. Laurent M. R., Panayi G. S., Shepherd P. Circulating immune complexes, serum immunoglobulins, and acute phase proteins in psoriasis and psoriatic arthritis. Ann Rheum Dis. 1981 Feb;40(1):66–69. doi: 10.1136/ard.40.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. McConkey B., Crockson R. A., Crockson A. P. The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants. Q J Med. 1972 Apr;41(162):115–125. [PubMed] [Google Scholar]
  8. McConkey B., Crockson R. A., Crockson A. P., Wilkinson A. R. The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis. Q J Med. 1973 Oct;42(168):785–791. [PubMed] [Google Scholar]
  9. McConkey B., Davies P., Crockson R. A., Crockson A. P., Butler M., Constable T. J., Amos R. S. Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis. Ann Rheum Dis. 1979 Apr;38(2):141–144. doi: 10.1136/ard.38.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Whicher J. T. The value of complement assays in clinical chemistry. Clin Chem. 1978 Jan;24(1):7–22. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES